Skip Ribbon Commands
Skip to main content

Medipure Pharmaceuticals Inc. and Medipure Holdings Inc.

Introduction and Overview

​​​On May 11, 2022, Medipure Pharmaceuticals Inc. ("MPI") and Medipure Holdings Inc. ("MHI", together with MPI, “Medipure" or the “Companies") both filed a Notice of Intention to Make a Proposal ("NOI") pursuant to Section 50.4(1) of the Bankruptcy and Insolvency Act (the "BIA", the “BIA Proceedings"). Deloitte Restructuring Inc. (“Deloitte") was appointed as the proposal Trustee of the Companies (the “Proposal Trustee"). Pursuant to Section 69 of the BIA, all proceedings against MPI and MHI are stayed as of that date.

On August 19, 2022 (the “Initial Order Date"), on application by the Companies, the Supreme Court of British Columbia (the “Court") made an order (the “Initial Order") granting the Companies protection from their creditors pursuant to the Companies Creditors Arrangement Act, R.S.C. 1985 as amended (the “CCAA"). Under the Initial Order, Deloitte Restructuring Inc. (“Deloitte") was appointed as the Monitor of the Companies with enhanced powers (the “Monitor").  These proceedings (the “CCAA Proceedings") are a continuation of the BIA Proceedings under which Deloitte was appointed as the Proposal Trustee.  The Initial Order discharges Deloitte as the Proposal Trustee of the Companies under the BIA Proceedings. 

On November 1, 2022, the assets of the Companies were sold to Apogee Pharmaceuticals Inc. and the Monitor was discharged subject to completion of its incidental duties to complete the CCAA Proceedings.

On February 2, 2023, the Monitor, pursuant to the provisions of the BIA and an order from the CCAA Proceedings, caused MPI and MHI to file assignments into bankruptcy for the general benefit of creditors.  Deloitte was appointed as licensed insolvency trustee of the estates of the bankrupts (the “Trustee").

Publicly available documents related to these proceedings will be posted to this website.​


Contact Information

​If you have any questions on this matter, please contact Jordan Yin of the Trustee's office at 604-640-5089 or joryin@deloitte.ca


Documents

The documents hosted on this page may not meet Provincial Accessibility standards. We will respond to any requests for accessible formats regarding public documents and address those requests in a timely and appropriate manner. Please contact us at ashkeene@deloitte.ca.

1)  Court Orders



2)  Reports



3)  Notices and Other Documents



4)  Service Lists



5)  Other Documents




6)  Relevant Links

BIA - NOI Proceedings

CCAA Proceedings

BIA - Bankruptcy Proceedings



Last updated Mar 7, 2023

​© 2020. Consultez les conditions d'utilisation pour obtenir plus de renseignements.

Deloitte désigne une ou plusieurs entités parmi Deloitte Touche Tohmatsu Limited (DTTL), société fermée à responsabilité limitée par garanties du Royaume-Uni, ainsi que son réseau de cabinets membres dont chacun constitue une entité juridique distincte et indépendante. DTTL (appelé également « Deloitte mondial ») n’offre aucun service aux clients. Pour obtenir une description détaillée de DTTL et de ses sociétés membres, veuillez consulter À propos de Deloitte.

Deloitte s’est engagé à servir tous ses clients, y compris ceux qui sont handicapés. Nous répondrons à toute demande pour des formats accessibles des documents publics, en temps opportun et de manière appropriée. Vous pouvez également consulter notre cplan de projet pluriannuel lié à la Loi sur l’accessibilité pour les personnes handicapées de l’Ontario (LAPHO).